Prof. Dr. med. Czaplinski founded Bellevue Medical Group in 2013 and has served as CEO and Medical Director ever since. Under his leadership, BMG has grown into a network of more than 20 locations and over 90 specialists, and is today the only privately operated Swiss institution holding Continuing Education Category A in neurology. Prior to founding BMG, Prof. Czaplinski was a long-standing senior physician at the Department of Neurology, University Hospital Basel, and most recently head of the Neurological-Neurosurgical Outpatient Clinic. Alongside his leadership responsibilities, he remains clinically active and, as a renowned specialist in multiple sclerosis, focuses primarily on treating MS patients at the Neurozentrum Bellevue and other centres of the group. He is the author of numerous scientific publications and a member of the Swiss, European, and American Neurological Societies.

Denise Daprai has been with Bellevue Medical Group since its foundation in 2013. She has over 20 years of experience in the Swiss healthcare sector and extensive knowledge of both inpatient and outpatient processes. At BMG she supervises day-to-day operations, is closely involved in the hiring and training of new employees, and oversees inpatient invoicing. Ms. Daprai is an experienced leader with a wide network of connections in the medical field allowing her to manage key customer relationships at BMG. Prior to joining BMG, Ms. Daprai was the head of administration for Prof. Dr. med. Adam Czaplinski and PD Dr. med. Manuel Meyer.

Ilia Louganski joined Bellevue Medical Group in 2026 as Chief Information Officer (CIO). Prior to joining BMG, he spent over 18 years leading strategic digitalisation and transformation projects at leading Swiss financial institutions, including UBS, Credit Suisse, and Allianz Suisse. In these roles, he gained extensive experience in managing complex IT landscapes and guiding demanding change processes. Drawing on his expertise in solution design, architecture, and digital transformation, he is responsible at BMG for the strategic development of the IT landscape and drives digitalisation, the deployment of AI solutions, and the expansion of data analytics capabilities across the company. Ilia Louganski holds a Bachelor’s degree in Economics from the University of St. Gallen (HSG) as well as a Certificate of Advanced Studies in FinTech from the University of Zurich.

Ms. Rijk Czaplinski has been Chief Operating Officer and Managing Director at Bellevue Medical Group since 2018. In this dual role, she is responsible for the entire operational leadership of the group, including organisation, human resources, processes, and locations. Prior to joining BMG, she served as Vice-President in Organisation and Personnel Development at Swiss Re. Before that, she worked at Novo Nordisk, initially on projects in South Africa and Brazil, and subsequently in Brussels and Zurich as Business Controller for the European Regional Office und in financial controlling for the Swiss Entity. She is a Chartered Financial Analyst (CFA) and holds a Master’s degree in Finance and Banking from the Warsaw School of Economics (SGH) as well as a CEMS Master’s in International Management.

Martina Riedo has worked at Bellevue Medical Group in Business Development since 2017. With over 25 years of experience in the hospital and healthcare sectors, she has previously worked at institutions such as the University Hospital Zurich, the Children’s Hospital Zurich, and the Cantonal Hospital Aarau. She also organized the annual congresses of the Swiss Society for Clinical Neurophysiology, which allowed her to build an extensive network of contacts. At Bellevue Medical Group, Ms. Riedo is responsible for corporate development. She oversees the establishment and growth of new centers, managing everything from construction responsibilities to marketing and team building at the new locations. She is also closely involved in strategic matters and their implementation, collaborating closely with the Medical Director, the Managing Director, and the Head of Operations at BMG.

Mikolaj Czaplinski joined Bellevue Medical Group in 2022 as Head of Health Economics and was appointed Chief Financial Officer in 2025. As CFO, he is responsible for the financial leadership of the group as well as for the management of investments and growth projects. Prior to joining BMG, he worked as an Investment Analyst at Orbis Investments in London and at the Private Investment Office Calibrium in Zurich. He also gained experience in Digital Health at the specialised investment fund Heal Capital in Berlin. Mikolaj Czaplinski holds an MA in Law from the University of Oxford as well as an MSc in Law and Finance from the London School of Economics and Political Science (LSE). His hobbies are travelling and sports.

Nicole Dietrich has been responsible for the strategic direction across Communication, Marketing, and Market Development as Chief Communications & Market Development Officer of Bellevue Medical Group since 2026. Prior to joining BMG, she shaped the brand’s repositioning and the development of a data-driven growth marketing approach as Head of Marketing DACH and member of the extended management team at BISON Group, the IT subsidiary of the fenaco cooperative. At Swisscom Health, she led marketing activities as Head of Marketing in the regulated health-tech environment, including audience-specific market activation and regulatory-compliant marketing strategies. Earlier, as Managing Director of the PADI Europe, Middle East & Africa Foundation, she oversaw its international positioning as well as communications and partnerships with partner organisations and governments. She is a Certified Marketing Manager (FH) and holds a Certificate of Advanced Studies (CAS) in Applied Psychology for Communication and Marketing from the University of Applied Sciences Northwestern Switzerland (FHNW). A SAFe Agilist certification and extensive experience in leading cross-functional teams and agile organisations round out her profile.

Reto Menzi has been Chief Business Officer since 2026. He is responsible for the strategic development of the company, with a focus on organisational and process optimisation, growth and expansion, as well as M&A. Prior to this, he worked as an Investment Manager in private equity, where he specialised in growth capital and the support of SMEs as a sparring partner in operational and strategic matters. In addition, he brings experience from his role on the board of directors of a family-owned company. He holds a Master’s degree in Accounting and Finance from the University of St. Gallen (HSG) as well as a CEMS Master’s in International Management from the Stockholm School of Economics (SSE) and the University of St. Gallen.